The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Regulatory T Cells Ameliorate Angiotensin II–Induced Cardiac Damage
Open accessAbstract
Background— Hypertensive target organ damage, especially cardiac hypertrophy with heart failure and arrhythmia, is a major source of morbidity and mortality. Angiotensin II, a major mediator of hypertension and cardiac damage, has proinflammatory properties. Inflammation and activation of the immune system play a pivotal role in pathogenesis of hypertensive target organ damage. However, the role of immunosuppressive CD4 + CD25 + regulatory T (Treg) cells in the pathogenesis of hypertensive target organ damage is unexplored. Methods and Results— We conducted adoptive transfer of Treg cells into angiotensin II–infused hypertensive mice. Treg cell recipients exhibited improved cardiac hypertrophy and less cardiac fibrosis despite sustained hypertension. Amelioration of cardiac morphology was accompanied by an improvement in arrhythmogenic electric remodeling, indicating the functional significance of the enhanced cardiac morphology. Delocalization of the connexin 43 gap junction protein is one of the major pathomechanisms in electric remodeling. Pronounced connexin 43 immunoreactivity was found at the lateral borders of cardiomyocytes in angiotensin II–treated mice. In contrast, connexin 43 was restricted to the intercalated disk regions in sham controls. Surprisingly, angiotensin II+Treg–treated mice showed normal connexin 43 gap junction protein localization. Adoptive Treg cell transfer resulted in a marked reduction in cardiac CD4 + , CD8 + , and CD69 + cell and macrophage infiltration. Conclusions— Immunosuppressive effects of transferred Treg cells ameliorated cardiac damage and accounted for the improved electric remodeling independently of blood pressure–lowering effects. Our results provide new insights into the pathogenesis of hypertensive cardiac damage and could therefore lead to new therapeutic approaches that involve manipulation of the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736
Natural regulatory T cells control the development of atherosclerosis in mice
Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A.-K. L., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., et al. (2006) · Nature Medicine · doi:10.1038/nm1343 · Cited by 1,100
Fontenot, J. D., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1179 · Cited by 950
Zannad, F., Alla, F., Dousset, B., Perez, A., & Pitt, B. (2000) · Circulation · doi:10.1161/01.cir.102.22.2700 · Cited by 947
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death
Haider, A. W., Larson, M. G., Benjamin, E. J., & Levy, D. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00407-0 · Cited by 800
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
Crowley, S. D., Gurley, S. B., Herrera, M. J., Ruiz, P., Griffiths, R., Kumar, A. P., Kim, H.-S., Smithies, O., Le, T. H., & Coffman, T. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605545103 · Cited by 714
Prognostic implications of left ventricular hypertrophy
Vakili, B. A., Okin, P. M., & Devereux, R. B. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113218 · Cited by 712
Foxp3 in control of the regulatory T cell lineage
Zheng, Y., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1455 · Cited by 701
Inflammation and angiotensin II
Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., & Egido, J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00271-6 · Cited by 694
McGeachy, M. J., Stephens, L. A., & Anderton, S. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3025 · Cited by 556
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans
Roncarolo, M.-G., & Battaglia, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2138 · Cited by 515
Misra, N., Bayry, J., Lacroix-Desmazes, S., Kazatchkine, M. D., & Kaveri, S. V. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4676 · Cited by 477
Hsu, C.-Y., McCulloch, C. E., Darbinian, J., Go, A. S., & Iribarren, C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.8.923 · Cited by 473
NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in Rats
Muller, D. N., Dechend, R., Mervaala, E. M. A., Park, J.-K., Schmidt, F., Fiebeler, A., Theuer, J., Breu, V., Ganten, D., Haller, H., et al. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.193 · Cited by 405
Self-citationEffective treatment of collagen‐induced arthritis by adoptive transfer of CD25+ regulatory T cells
Morgan, M. E., Flierman, R., van Duivenvoorde, L. M., Witteveen, H. J., van Ewijk, W., van Laar, J. M., de vries, R. R. P., & Toes, R. E. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21195 · Cited by 385
Sun, M., Chen, M., Dawood, F., Zurawska, U., Li, J. Y., Parker, T., Kassiri, Z., Kirshenbaum, L. A., Arnold, M., Khokha, R., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.643585 · Cited by 383
Szanya, V., Ermann, J., Taylor, C., Holness, C., & Fathman, C. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2461 · Cited by 373
Role of Naturally Occurring CD4 + CD25 + Regulatory T Cells in Experimental Atherosclerosis
Mor, A., Planer, D., Luboshits, G., Afek, A., Metzger, S., Chajek-Shaul, T., Keren, G., & George, J. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000259365.31469.89 · Cited by 348
CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset
Kleinewietfeld, M., Puentes, F., Borsellino, G., Battistini, L., Rötzschke, O., & Falk, K. (2005) · Blood · doi:10.1182/blood-2004-07-2505 · Cited by 312
Self-citationAngiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
Nataraj, C., Oliverio, M. I., Mannon, R. B., Mannon, P. J., Audoly, L. P., Amuchastegui, C. S., Ruiz, P., Smithies, O., & Coffman, T. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7451 · Cited by 308
Immunosuppressive Treatment Protects Against Angiotensin II-Induced Renal Damage
Muller, D. N., Shagdarsuren, E., Park, J.-K., Dechend, R., Mervaala, E., Hampich, F., Fiebeler, A., Ju, X., Finckenberg, P., Theuer, J., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64445-8 · Cited by 278
Self-citationHuman regulatory T cells and their role in autoimmune disease
Baecher‐Allan, C., & Hafler, D. A. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00417.x · Cited by 266
Wachtell, K., Okin, P. M., Olsen, M. H., Dahlöf, B., Devereux, R. B., Ibsen, H., Kjeldsen, S. E., Lindholm, L. H., Nieminen, M. S., & Thygesen, K. (2007) · Circulation · doi:10.1161/circulationaha.106.666594 · Cited by 226
Jurewicz, M., McDermott, D. H., Sechler, J. M., Tinckam, K., Takakura, A., Carpenter, C. B., Milford, E., & Abdi, R. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070707 · Cited by 210
Tregs and transplantation tolerance
Walsh, P. T., Taylor, D. K., & Turka, L. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423238 · Cited by 209
Volders, P. G. A., Sipido, K. R., Vos, M. A., Kulcsár, A., Verduyn, S. C., & Wellens, H. J. J. (1998) · Circulation · doi:10.1161/01.cir.98.11.1136 · Cited by 183
Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension
Crowley, S. D., Frey, C. W., Gould, S., Griffiths, R., Ruiz, P., Burchette, J. L., Howell, D. N., Makhanova, N., Yan, M., Kim, H., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00527.2007 · Cited by 161
Hayek, T., Attias, J., Coleman, R., Brodsky, S., Smith, J., Breslow, J. L., & Keidar, S. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00239-4 · Cited by 161
Sawaya, S. E., Rajawat, Y. S., Rami, T. G., Szalai, G., Price, R. L., Sivasubramanian, N., Mann, D. L., & Khoury, D. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00285.2006 · Cited by 148
CD4+CD25+Regulatory T Cells and Their Therapeutic Potential
Randolph, D. A., & Fathman, C. G. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131337 · Cited by 134
Mahajan, D., Wang, Y., Qin, X., Wang, Y., Zheng, G., Wang, Y. M., Alexander, S. I., & Harris, D. C. H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080842 · Cited by 133
Complement Activation in Angiotensin II–Induced Organ Damage
Shagdarsuren, E., Wellner, M., Bräsen, J. H., Park, J.-K., Fiebeler, A., Henke, N., Dechend, R., Gratze, P., Luft, F. C., & Müller, D. N. (2005) · Circulation Research · doi:10.1161/01.res.0000182677.89816.38 · Cited by 128
Self-citationIs angiotensin II a proliferative factor of cardiac fibroblasts?
Bouzegrhane, F., & Thibault, G. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00448-5 · Cited by 109
Aspirin inhibits NF‐κB and protects from angiotensin II‐induced organ damage
Müller, D. N., Heissmeyer, V., Dechend, R., Hampich, F., Park, J.-K., Fiebeler, A., Shagdarsuren, E., Theuer, J., Elger, M., Pilz, B., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0843fje · Cited by 100
Self-citationRials, S. J., Wu, Y., Ford, N., Pauletto, F. J., Abramson, S. V., Rubin, A., Marinchak, R. A., & Kowey, P. R. (1995) · Circulation · doi:10.1161/01.cir.91.2.426 · Cited by 85
Mervaala, E. M. A., Müller, D. N., Park, J.-K., Dechend, R., Schmidt, F. H., Fiebeler, A., Bieringer, M., Breu, V., Ganten, D., Haller, H. G., et al. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.360 · Cited by 74
Self-citationA Pressor Response Associated with Drinking in Rats
Hoffman, W. E., Phillips, M. I., Wilson, E., & Schmid, P. G. (1977) · Experimental Biology and Medicine · doi:10.3181/00379727-154-39617a · Cited by 41
Novel Role for Inhibitor of Differentiation 2 in the Genesis of Angiotensin II–Induced Hypertension
Gratze, P., Dechend, R., Stocker, C., Park, J.-K., Feldt, S., Shagdarsuren, E., Wellner, M., Gueler, F., Rong, S., Groß, V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.760116 · Cited by 36
Self-citationKonstantino, Y., Kusniec, J., Reshef, T., David‐Zadeh, O., Mazur, A., Strasberg, B., Battler, A., & Haim, M. (2007) · Clinical Cardiology · doi:10.1002/clc.20110 · Cited by 30
Cited by
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Inflammation, Immunity, and Hypertension
Harrison, D. G., Guzik, T. J., Lob, H. E., Madhur, M. S., Marvar, P. J., Thabet, S. R., Vinh, A., & Weyand, C. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.163576 · Cited by 871
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage
Bartolomaeus, H., Balogh, A., Yakoub, M., Homann, S., Markó, L., Höges, S., Tsvetkov, D., Krannich, A., Wundersitz, S., Avery, E. G., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036652 · Cited by 815
Self-citation
Metadata
- Authors
- Kvakan, H., Kleinewietfeld, M., Qadri, F., Park, J.-K., Fischer, R., Schwarz, I., Rahn, H.-P., Plehm, R., Wellner, M., Elitok, S., Gratze, P., Dechend, R., Luft, F. C., & Muller, D. N.
- Venue
- Circulation
- Published
- 2009-06-09
- Volume
- 119
- Issue
- 22
- Pages
- 2904-2912
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2069830368
- Cited by
- 339
- References
- 43
- FWCI
- 12.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.